HealthTech Accelerator Company


We are pioneers in the field of regenerative medicine, developing personalized human tissues for transplantation. The current focus area is the development of fully biological, personalized blood vessels that can be used to replace diseased or non-functioning blood vessels in patients. In contrast to conventional transplants, where the patient has to be put on life-long immunosuppression with severe side-effects, VERIGRAFT’s technology does not require immunosuppression. With this unique, patented and improved alternative to existing treatments, VERIGRAFT strives to deliver a life changing impact to patients and provide major benefits for hospitals, healthcare providers and society – globally.

Visit site